Science Explorer Back to mapMap
Discussion
Researcher · Probiodrug (Germany) · Germany

Ingo Schulz

Ingo Schulz publishes mostly in Biomedical Engineering, Oncology and Cellular and Molecular Neuroscience, on topics such as 3D Printing in Biomedical Research, Peptidase Inhibition and Analysis and Neuropeptides and Animal Physiology.

OpenAlex
World rank
#3,568,601
of 7,710,434 ranked researchers
Rank in Germany
#178,474
of 364,343
Works
21
Citations
591
Citations per work
28.1
h-index
12
i10-index 13Top 51% in Biomedical Engineering
Ingo Schulz

What does Ingo Schulz research?

Ingo Schulz's work is mostly in Engineering (26%), Medicine (17%), Biochemistry, Genetics and Molecular Biology (14%).

Everything else: 7 works · 31.1% of their workPhysical Sciences: 5 works · 25.9% of their workEngineering: 5 works · 25.9% of their workBiomedical Engineering: 5 works · 25.9% of their workLife Sciences: 5 works · 25.8% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 13.8% of their workCancer Research: 1 works · 6.9% of their workMolecular Biology: 1 works · 6.9% of their workNeuroscience: 2 works · 8.6% of their workCellular and Molecular Neuroscience: 2 works · 8.6% of their workImmunology and Microbiology: 1 works · 3.4% of their workImmunology: 1 works · 3.4% of their workHealth Sciences: 4 works · 17.2% of their workMedicine: 4 works · 17.2% of their workOncology: 4 works · 17.2% of their workTHEIR WORKIngo Schulz21works
Life Sciences26%Physical Sciences26%Health Sciences17%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else731.1%
    1. Engineering525.9%
    1. Biochemistry, Genetics and Molecular Biology313.8%
    2. Neuroscience28.6%
    3. Immunology and Microbiology13.4%
    1. Medicine417.2%
  1. 1Biomedical Engineering26% of their works
  2. 2Oncology17% of their works
  3. 3Cellular and Molecular Neuroscience9% of their works
  4. 4Cancer Research7% of their works
  5. 5Molecular Biology7% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe Ingo Schulz's research?

The keywords of their largest research topics: Angiogenesis, Microfluidics, Bioprinting, Fibroblast Activation Protein, Tissue Engineering, Tumor Microenvironment, Cancer Progression and Neuropeptides.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Angiogenesis92 topics
  2. Microfluidics72 topics
  3. Bioprinting61 topic
  4. Fibroblast Activation Protein61 topic
  5. Tissue Engineering61 topic
  6. Tumor Microenvironment61 topic
  7. Cancer Progression52 topics
  8. Neuropeptides51 topic
  9. Receptors51 topic
  10. Continuous Flow Chemistry41 topic
  11. Droplet Formation41 topic
  12. Acoustic Manipulation31 topic
  13. Matrix Metalloproteinases31 topic
  14. Particle Separation31 topic
  15. Tissue Inhibitors of Metalloproteinases31 topic
  16. Calcineurin21 topic
  17. Ion-Selective Electrodes21 topic
  18. NFAT21 topic
  19. Optical Sensors21 topic

Where does Ingo Schulz work?

Ingo Schulz's main affiliation in the publication record is Probiodrug (Germany), Germany.

How many publications and citations does Ingo Schulz have?

OpenAlex counts 21 works and 591 citations for Ingo Schulz, an h-index of 12, ranking #3,568,601 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ingo Schulz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.